LIC MF Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.08% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
1 - Minimum Investment₹5000
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹98 Cr
- Created on4 Feb 2019
Fund Ranking
#6
/ 16 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month21.4%
- 1 Year14.8%
- 3 Year (CAGR)20.9%
- All Time (CAGR)17.8%
Category Return
- 6 Month19.9%
- 1 Year15.7%
- 3 Year (CAGR)20.6%
- All Time (CAGR)-
Asset Allocation
- Equity96.9%
- Other3.1%
Top 5 Holdings
Top 5 Sectors
- Apollo Hospitals Enterprise6.62%
- Aurobindo Pharma5.02%
- Ipca Laboratories2.97%
- Neuland Laboratories5.57%
- Sun Pharmaceutical Industries10.69%
Fund Information
- Expense Ratio2.72%
- Exit LoadExit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
- Lock-In PeriodNo Lock-In
Managed By
Karan Doshi
July 2023 - Present
Sudhanshu Asthana
April 2026 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 0.89 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 15.84 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. -1.28 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.94